A higher generation of implantable hearing technology is slated to be soon released in India by Cochlear Limited, engaged in cochlear and bone conduction implant technology.
The company is releasing three new technologies – Cochlear Hybrid, Cochlear Nucleus 5, and Cochlear Baha BP100 – designed for hearing impaired people across a wide spectrum.
“For more than 25 years now, Cochlear has focused on developing technologies which addressess different types of hearing loss. The three new offerings have been designed for unique needs of people suffering from partial deafness, moderate to profound deafness, and single-sided deafness. Each one is, more sophisticated and more feature rich than ever before, and that means a world of sound can be opened up to millions of people,” says Mark Salmon, president, Asia Pacific, Cochlear Limited.
Cochlear Nucleus 5 is thin, strong, stylish and an easy-to-use for both adults and children experiencing moderate to profound hearing loss. Cochlear Hybrid addresses distinctive needs of people with steeply sloping hearing losses in the high frequency region.
On the other hand, Cochlear Baha BP100 is supposed to be world’s first hi-tech direct bone conduction sound processor that can automatically process sound. Also, this device delivers more than 25 per cent improvement in speech understanding in noisy situations. It comes in a range of colours and also has a Europin audio connector for lifestyle accessories such as FM systems, MP3 players and Bluetooth adaptors.